These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20009935)

  • 1. The patient with coronary stents and antiplatelet agents: what to do and how to deal?
    Bornemann H; Prüller F; Metzler H
    Eur J Anaesthesiol; 2010 May; 27(5):406-10. PubMed ID: 20009935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaesthesia in patients with drug-eluting stents.
    Metzler H; Huber K; Kozek-Langenecker S
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):55-9. PubMed ID: 18195611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.
    Chen TH; Matyal R
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):256-73. PubMed ID: 21059610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).
    Korte W; Cattaneo M; Chassot PG; Eichinger S; von Heymann C; Hofmann N; Rickli H; Spannagl M; Ziegler B; Verheugt F; Huber K
    Thromb Haemost; 2011 May; 105(5):743-9. PubMed ID: 21437351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery stents: II. Perioperative considerations and management.
    Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
    Moussa ID; Colombo A
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1047-54. PubMed ID: 19626692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative management of the patient with a coronary stent.
    Popescu WM
    Curr Opin Anaesthesiol; 2010 Feb; 23(1):109-15. PubMed ID: 19901828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-cardiac surgery and antiplatelet therapy following coronary artery stenting.
    Luckie M; Khattar RS; Fraser D
    Heart; 2009 Aug; 95(16):1303-8. PubMed ID: 19218260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative management of patients with coronary stents.
    Brilakis ES; Banerjee S; Berger PB
    J Am Coll Cardiol; 2007 Jun; 49(22):2145-50. PubMed ID: 17543633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncardiac surgery and bleeding after percutaneous coronary intervention.
    To AC; Armstrong G; Zeng I; Webster MW
    Circ Cardiovasc Interv; 2009 Jun; 2(3):213-21. PubMed ID: 20031718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents.
    van Kuijk JP; Flu WJ; Schouten O; Hoeks SE; Schenkeveld L; de Jaegere PP; Bax JJ; van Domburg RT; Serruys PW; Poldermans D
    Am J Cardiol; 2009 Nov; 104(9):1229-34. PubMed ID: 19840567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary stents and noncardiac surgery.
    Riddell JW; Chiche L; Plaud B; Hamon M
    Circulation; 2007 Oct; 116(16):e378-82. PubMed ID: 17938292
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.
    Sharma A; Berkeley A
    J Clin Anesth; 2009 Nov; 21(7):517-20. PubMed ID: 20006260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents.
    Eberli D; Chassot PG; Sulser T; Samama CM; Mantz J; Delabays A; Spahn DR
    J Urol; 2010 Jun; 183(6):2128-36. PubMed ID: 20399452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.
    Paradis JM; Ducrocq G; Tanguay JF
    Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.